Company / Free Cash Flow
Centessa Pharmaceuticals plc Free Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$194.2M
FY2025
5-year range
-$201.7M / -$135.3M
FY2021-FY2025
Trend
-36.7%
vs FY2024
Sector context
#150 of 195
Health Care
What the data says
Centessa Pharmaceuticals plc's free cash flow of -$194M is lower than 77% of companies in the Health Care sector (FY2025). Declined from -$161M to -$194M over the past 2 years.
Based on SEC 10-K filings.
-$194M in FY2025.
Declined from -$161M to -$194M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 195This company -$194.2M Sector average $467.5M
▼
-141.5% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 36.7% year-over-year.
- Ranks #150 out of 195 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2019.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$194.2M | -36.7% |
| FY2024 | -$142.1M | +11.5% |
| FY2023 | -$160.5M | +20.4% |
| FY2022 | -$201.7M | -49.1% |
| FY2021 | -$135.3M | -1172.8% |
| FY2020 | -$10.6M | -82.5% |
| FY2019 | -$5.8M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026